Europe Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
The Europe Continuous Glucose Monitoring Device (CGMD) Market is poised for significant growth, projected to reach approximately US$ 9,935.2 million by 2031, up from US$ 3,920.3 million in 2024. This growth trajectory indicates a robust compound annual growth rate (CAGR) of 14.4% from 2025 to 2031.
Executive Summary and Market Analysis
The CGMD market in Europe encompasses key countries including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The landscape of continuous glucose monitoring is undergoing a transformative shift, driven by advancements in healthcare policies, technological innovations, and the emergence of non-invasive solutions. This evolution signifies a transition from traditional episodic glucose checks to a more integrated and real-time approach to diabetes management.
In Northern and Central Europe, particularly in Germany and the Nordic countries, statutory health systems have broadened CGM reimbursement policies to include insulin-dependent patients. Germany, which accounts for over 20% of the European CGM market, has established structured clinical pathways that facilitate the initiation of CGM shortly after diabetes treatment begins. The National Health Service (NHS) in England, following NICE recommendations, supports CGM and intermittently scanned flash glucose monitoring for all type 1 diabetics and select type 2 patients. Additionally, innovative models such as virtual wards in the UK and France have introduced CGM-enabled discharge kits, which have proven effective in reducing hospital readmissions and promoting CGM adoption in both inpatient and remote care settings.
The market is also witnessing the rise of integrated devices, such as Medtronic's MiniMed 780G closed-loop system, which combines a disposable CGM sensor with automated insulin delivery. Furthermore, Roche's AI-driven SmartGuide, which predicts hypoglycemia, exemplifies the convergence of CGM technology with predictive analytics and automated insulin delivery systems. In France, the full national reimbursement for Dexcom One for type 2 patients using basal insulin marks a significant milestone in expanding CGM access beyond the traditional type 1 diabetes demographic.
Strategic Insights
Market Segmentation Analysis
The Europe CGMD market is segmented by product, application, testing sites, and end users:
A significant growth opportunity in the CGM market lies in enhancing accessibility in emerging and underserved regions, where diabetes prevalence is rapidly increasing. Despite the rising incidence of diabetes, access to modern diabetes management tools remains limited in these areas. Humanitarian organizations are beginning to incorporate CGMs into chronic care programs for displaced populations and refugees, particularly those with Type 1 diabetes. CGMs are particularly beneficial in low-resource settings as they reduce the need for frequent finger sticks and facilitate more autonomous diabetes management.
Innovations in low-cost, non-invasive technology, coupled with the expansion of mobile health infrastructure and local manufacturing, are helping to dismantle long-standing barriers to access. For CGM manufacturers, healthcare providers, and digital health companies, investing in scalable, culturally sensitive, and affordable solutions for these populations presents a unique opportunity to expand market share while addressing critical global health equity challenges in chronic disease management.
Country Insights
The CGMD market is further analyzed by country, with Germany leading the market in 2024. Germany's position as a global leader in CGM adoption is supported by its comprehensive statutory health insurance system, progressive reimbursement policies, and the integration of digital health innovations. Since the pivotal 2016 decision by the Federal Joint Committee (G-BA), real-time CGM has been covered by statutory health insurers for patients who meet specific criteria, such as being insulin-dependent and completing structured CGM training.
As of 2022, the prevalence of CGM use among children and adolescents with type 1 diabetes in Germany was reported at 94.9%. The country also ranks third in the number of adults with diabetes, with approximately 6.5 million adults affected in 2024. The affordability of CGMs is enhanced by insurance coverage, with minimal out-of-pocket costs for patients.
Germany's digital health infrastructure, bolstered by the Digital Healthcare Act (DiGA), promotes the integration of CGM data into patient care pathways, further enhancing the reach and effectiveness of CGM technologies. Hospitals in regions like Bavaria and North Rhine-Westphalia are piloting CGM-enhanced monitoring systems, which facilitate remote supervision of glucose metrics, thereby improving patient outcomes.
Executive Summary and Market Analysis
The CGMD market in Europe encompasses key countries including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The landscape of continuous glucose monitoring is undergoing a transformative shift, driven by advancements in healthcare policies, technological innovations, and the emergence of non-invasive solutions. This evolution signifies a transition from traditional episodic glucose checks to a more integrated and real-time approach to diabetes management.
In Northern and Central Europe, particularly in Germany and the Nordic countries, statutory health systems have broadened CGM reimbursement policies to include insulin-dependent patients. Germany, which accounts for over 20% of the European CGM market, has established structured clinical pathways that facilitate the initiation of CGM shortly after diabetes treatment begins. The National Health Service (NHS) in England, following NICE recommendations, supports CGM and intermittently scanned flash glucose monitoring for all type 1 diabetics and select type 2 patients. Additionally, innovative models such as virtual wards in the UK and France have introduced CGM-enabled discharge kits, which have proven effective in reducing hospital readmissions and promoting CGM adoption in both inpatient and remote care settings.
The market is also witnessing the rise of integrated devices, such as Medtronic's MiniMed 780G closed-loop system, which combines a disposable CGM sensor with automated insulin delivery. Furthermore, Roche's AI-driven SmartGuide, which predicts hypoglycemia, exemplifies the convergence of CGM technology with predictive analytics and automated insulin delivery systems. In France, the full national reimbursement for Dexcom One for type 2 patients using basal insulin marks a significant milestone in expanding CGM access beyond the traditional type 1 diabetes demographic.
Strategic Insights
Market Segmentation Analysis
The Europe CGMD market is segmented by product, application, testing sites, and end users:
- By Product: The market is divided into Sensors, Transmitters, and Receivers, with Sensors holding the largest market share in 2024.
- By Application: The market is categorized into Type 1 Diabetes and Type 2 Diabetes, where Type 2 Diabetes is expected to dominate the market share in 2024.
- By Testing Sites: The segments include Fingertip Testing and Alternate Site Testing, with Fingertip Testing leading in market share.
- By End User: The market is segmented into Hospitals and Clinics and Self or Homecare, with Self or Homecare being the largest segment in 2024.
A significant growth opportunity in the CGM market lies in enhancing accessibility in emerging and underserved regions, where diabetes prevalence is rapidly increasing. Despite the rising incidence of diabetes, access to modern diabetes management tools remains limited in these areas. Humanitarian organizations are beginning to incorporate CGMs into chronic care programs for displaced populations and refugees, particularly those with Type 1 diabetes. CGMs are particularly beneficial in low-resource settings as they reduce the need for frequent finger sticks and facilitate more autonomous diabetes management.
Innovations in low-cost, non-invasive technology, coupled with the expansion of mobile health infrastructure and local manufacturing, are helping to dismantle long-standing barriers to access. For CGM manufacturers, healthcare providers, and digital health companies, investing in scalable, culturally sensitive, and affordable solutions for these populations presents a unique opportunity to expand market share while addressing critical global health equity challenges in chronic disease management.
Country Insights
The CGMD market is further analyzed by country, with Germany leading the market in 2024. Germany's position as a global leader in CGM adoption is supported by its comprehensive statutory health insurance system, progressive reimbursement policies, and the integration of digital health innovations. Since the pivotal 2016 decision by the Federal Joint Committee (G-BA), real-time CGM has been covered by statutory health insurers for patients who meet specific criteria, such as being insulin-dependent and completing structured CGM training.
As of 2022, the prevalence of CGM use among children and adolescents with type 1 diabetes in Germany was reported at 94.9%. The country also ranks third in the number of adults with diabetes, with approximately 6.5 million adults affected in 2024. The affordability of CGMs is enhanced by insurance coverage, with minimal out-of-pocket costs for patients.
Germany's digital health infrastructure, bolstered by the Digital Healthcare Act (DiGA), promotes the integration of CGM data into patient care pathways, further enhancing the reach and effectiveness of CGM technologies. Hospitals in regions like Bavaria and North Rhine-Westphalia are piloting CGM-enhanced monitoring systems, which facilitate remote supervision of glucose metrics, thereby improving patient outcomes.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - EUROPE MARKET ANALYSIS
5.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
5.2 Europe Continuous Glucose Monitoring Device (CGMD) Market Forecast and Analysis
6. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY PRODUCT
6.1 Sensors
6.1.1 Overview
6.1.2 Sensors: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Transmitters
6.2.1 Overview
6.2.2 Transmitters: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Receivers
6.3.1 Overview
6.3.2 Receivers: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Type 1 Diabetes
7.1.1 Overview
7.1.2 Type 1 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Type 2 Diabetes
7.2.1 Overview
7.2.2 Type 2 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY TESTING SITES
8.1 Fingertip Testing
8.1.1 Overview
8.1.2 Fingertip Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Alternate Site Testing
8.2.1 Overview
8.2.2 Alternate Site Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Self or Homecare
9.2.1 Overview
9.2.2 Self or Homecare: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.1.2.2.2 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.1.2.2.3 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.1.2.2.4 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.2.3.3 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.2.3.3.2 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.2.3.3.3 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.2.3.3.4 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.3.4.4 France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.3.4.4.2 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.3.4.4.3 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.3.4.4.4 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.4.5.5 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.4.5.5.2 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.4.5.5.3 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.4.5.5.4 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.5.6.6 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.5.6.6.2 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.5.6.6.3 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.5.6.6.4 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.6.7.7 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.6.7.7.2 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.6.7.7.3 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.6.7.7.4 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Tandem Diabetes Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed Holding AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dexcom Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 i-SENS Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Senseonics Holdings Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 A. Menarini Diagnostics s.r.l
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Medtrum Technologies Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - EUROPE MARKET ANALYSIS
5.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
5.2 Europe Continuous Glucose Monitoring Device (CGMD) Market Forecast and Analysis
6. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY PRODUCT
6.1 Sensors
6.1.1 Overview
6.1.2 Sensors: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Transmitters
6.2.1 Overview
6.2.2 Transmitters: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Receivers
6.3.1 Overview
6.3.2 Receivers: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Type 1 Diabetes
7.1.1 Overview
7.1.2 Type 1 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Type 2 Diabetes
7.2.1 Overview
7.2.2 Type 2 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY TESTING SITES
8.1 Fingertip Testing
8.1.1 Overview
8.1.2 Fingertip Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Alternate Site Testing
8.2.1 Overview
8.2.2 Alternate Site Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Self or Homecare
9.2.1 Overview
9.2.2 Self or Homecare: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.1.2.2.2 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.1.2.2.3 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.1.2.2.4 Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.2.3.3 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.2.3.3.2 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.2.3.3.3 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.2.3.3.4 United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.3.4.4 France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.3.4.4.2 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.3.4.4.3 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.3.4.4.4 France: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.4.5.5 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.4.5.5.2 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.4.5.5.3 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.4.5.5.4 Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.5.6.6 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.5.6.6.2 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.5.6.6.3 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.5.6.6.4 Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.6.7.7 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.6.7.7.2 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.6.7.7.3 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.6.7.7.4 Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Tandem Diabetes Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed Holding AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dexcom Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 i-SENS Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Senseonics Holdings Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 A. Menarini Diagnostics s.r.l
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Medtrum Technologies Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Continuous Glucose Monitoring Device (CGMD) Market Segmentation
Table 3. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 7. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 10. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 12. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 16. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 20. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 23. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 24. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 26. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 28. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 31. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 32. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 33. Heat Map Analysis by Key Players
Table 1. Europe Continuous Glucose Monitoring Device (CGMD) Market Segmentation
Table 3. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 7. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 10. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 12. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 16. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 20. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 23. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 24. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 26. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 28. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 31. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 32. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 33. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Europe Continuous Glucose Monitoring Device (CGMD) Market Segmentation - Country
Figure 4. Europe Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product, 2024 and 2031
Figure 8. Sensors: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Transmitters: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Receivers: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application, 2024 and 2031
Figure 12. Type 1 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Type 2 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites, 2024 and 2031
Figure 15. Fingertip Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Alternate Site Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User, 2024 and 2031
Figure 18. Hospitals and Clinics: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Self or Homecare: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Europe Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 21. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
Figure 1. Europe Continuous Glucose Monitoring Device (CGMD) Market Segmentation - Country
Figure 4. Europe Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product, 2024 and 2031
Figure 8. Sensors: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Transmitters: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Receivers: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application, 2024 and 2031
Figure 12. Type 1 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Type 2 Diabetes: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites, 2024 and 2031
Figure 15. Fingertip Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Alternate Site Testing: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Europe Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User, 2024 and 2031
Figure 18. Hospitals and Clinics: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Self or Homecare: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Europe Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 21. Germany: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Kingdom: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. France: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Italy: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Spain: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of Europe: Europe Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
